Similar Search Results

Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …

Persistent link: https://www.econbiz.de/10013285854

Reference Pricing with Endogenous Generic Entry

Brekke, Kurt Richard - 2015

In this paper we study the effect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic producers in terms of prices. In the market there are two types of...

Persistent link: https://www.econbiz.de/10013024341

Margins and market shares : pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …

Persistent link: https://www.econbiz.de/10009691207

Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on … several off-patent molecules before and after the policy reform. Off-patent drugs not subject to RP serve as our control group …

Persistent link: https://www.econbiz.de/10008749029

Margins and Market Shares : Pharmacy Incentives for Generic Substitution

Brekke, Kurt Richard - 2010

We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...

Persistent link: https://www.econbiz.de/10013139185